HowShorted

How shorted is Tango Therapeutics, Inc.?

More shorted than 99% of the 2,877 ranked US companies

31.26%
of shares outstanding reported short · settlement date 31 Jul 2026
vs previous report
+1.32
5 reports (~10 weeks)
+8.97
Aggregate net short position time series for Tango Therapeutics, Inc.
Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

Cite this page

History

Settlement dateShort %Change
31 Jul 202631.26%+1.32
15 Jul 202629.94%+0.50
30 Jun 202629.44%+5.58
15 Jun 202623.86%+0.39
29 May 202623.47%+1.18
15 May 202622.29%−4.52
30 Apr 202626.81%−1.39
15 Apr 202628.20%−0.09
31 Mar 202628.29%−4.82
13 Mar 202633.11%−1.05
27 Feb 202634.16%−0.79
13 Feb 202634.95%+0.91
30 Jan 202634.04%+2.28
15 Jan 202631.76%+2.06
31 Dec 202529.70%+4.77
15 Dec 202524.93%+0.23
28 Nov 202524.70%+1.80
14 Nov 202522.90%+1.06
31 Oct 202521.84%−10.83
15 Oct 202532.67%+2.28
30 Sep 202530.39%+6.30
15 Sep 202524.09%+1.26
29 Aug 202522.83%+0.22
15 Aug 202522.61%+2.41
31 Jul 202520.20%–

Frequently asked questions

How shorted is Tango Therapeutics, Inc. right now?
31.26% of Tango Therapeutics, Inc.'s (TNGX) shares outstanding were reported short for settlement date 31 Jul 2026, per FINRA's consolidated short interest report.
What does this number include?
FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?
US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Which funds are short?
US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.